In mouse models, pharmacologic inhibitors of the PI3K pathway diminished tumor proliferation in tumor-bearing single-mutated KITV558Δ/+ mice, indicating that PI3K kinase makes a major contribution to tumor cell proliferation in established GISTs [133]. Here, PIK3CD is linked to neoplasm.